Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery

Anti-CD20 therapies decrease the humoral response to SARS-CoV-2 immunization. We aimed to determine the extent of the humoral response to SARS-CoV-2 antigens in correlation with peripheral B-cell dynamics among patients with central nervous system inflammatory disorders treated with anti-CD20 medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Feige, Julia, Berek, Klaus, Seiberl, Michael, Hilpold, Patrick, Hitzl, Wolfgang, Di Pauli, Franziska, Hegen, Harald, Deisenhammer, Florian, Trinka, Eugen, Harrer, Andrea, Wipfler, Peter, Moser, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680461/
https://www.ncbi.nlm.nih.gov/pubmed/36412697
http://dx.doi.org/10.3390/neurolint14040075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680461/
https://www.ncbi.nlm.nih.gov/pubmed/36412697
http://dx.doi.org/10.3390/neurolint14040075

Ejemplares similares